Venture financing for mRNA-based innovator vaccines saw an 82% decline from $510 million in 2023 to $90 million in 2025 ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

The nation's greatest struggles, from layoffs and Medicaid cuts to the fiery immigration debate, are playing out in rural ...

According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to reach USD ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

Triin Laisk, Associate Professor of Genomics and Reproductive Genetics at the University of Tartu, has become the first ...

The biotech and pharma Industries are growing healthcare solutions for the future. These locations support the industry's ...

Vaccine-maker Moderna has opened a new manufacturing base in Oxfordshire in a boost to the pharmaceutical industry after other major firms shelved or paused planned UK investments this year. The ...

New Modern Innovation and Technology Centre opened as government further boosts life sciences sector with £50 million fund.

Demings held a press conference to knock down Ingoglia’s conclusions, saying increased spending could be tied to a growing ...

The antisense oligonucleotides market offers growth opportunities across diverse disease indications, with promising ...

The vaccine, the ministry noted, will help protect from “the potential dramatic impact from FMD on the supply of meat, milk, ...